These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

133 related items for PubMed ID: 34062170

  • 1. Corilagin ameliorates atherosclerosis by regulating MMP-1, -2, and -9 expression in vitro and in vivo.
    Tao Y, Zhang L, Yang R, Yang Y, Jin H, Zhang X, Hu Q, He B, Shen Z, Chen P.
    Eur J Pharmacol; 2021 Sep 05; 906():174200. PubMed ID: 34062170
    [Abstract] [Full Text] [Related]

  • 2. Corilagin Ameliorates Atherosclerosis in Peripheral Artery Disease via the Toll-Like Receptor-4 Signaling Pathway in vitro and in vivo.
    Li Y, Wang Y, Chen Y, Wang Y, Zhang S, Liu P, Chen Z, Song P, Luo L, Luo Y, Dang Y, Zhao L.
    Front Immunol; 2020 Sep 05; 11():1611. PubMed ID: 32849545
    [Abstract] [Full Text] [Related]

  • 3. Antiatherosclerotic effects of corilagin via suppression of the LOX-1/MyD88/NF-κB signaling pathway in vivo and in vitro.
    He B, Chen D, Zhang X, Yang R, Yang Y, Chen P, Shen Z.
    J Nat Med; 2022 Mar 05; 76(2):389-401. PubMed ID: 35064897
    [Abstract] [Full Text] [Related]

  • 4. Corilagin relieves atherosclerosis via the toll-like receptor 4 signaling pathway in vascular smooth muscle cells.
    Wang Y, Li Y, Chen Y, Mao J, Ji J, Zhang S, Liu P, Pronyuk K, Fisher D, Dang Y, Zhao L.
    Int J Immunopathol Pharmacol; 2024 Mar 05; 38():3946320241254083. PubMed ID: 38869980
    [Abstract] [Full Text] [Related]

  • 5. Corilagin alleviates atherosclerosis by inhibiting NLRP3 inflammasome activation via the Olfr2 signaling pathway in vitro and in vivo.
    Mao J, Chen Y, Zong Q, Liu C, Xie J, Wang Y, Fisher D, Hien NTT, Pronyuk K, Musabaev E, Li Y, Zhao L, Dang Y.
    Front Immunol; 2024 Mar 05; 15():1364161. PubMed ID: 38803504
    [Abstract] [Full Text] [Related]

  • 6. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
    Wang N, Zhang X, Ma Z, Niu J, Ma S, Wenjie W, Chen J.
    Biomed Pharmacother; 2020 Mar 05; 123():109729. PubMed ID: 31887543
    [Abstract] [Full Text] [Related]

  • 7. Mesenchymal Stem Cells Stabilize Atherosclerotic Vulnerable Plaque by Anti-Inflammatory Properties.
    Wang SS, Hu SW, Zhang QH, Xia AX, Jiang ZX, Chen XM.
    PLoS One; 2015 Mar 05; 10(8):e0136026. PubMed ID: 26288013
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Corilagin suppresses RANKL-induced osteoclastogenesis and inhibits oestrogen deficiency-induced bone loss via the NF-κB and PI3K/AKT signalling pathways.
    Lu J, Ye C, Huang Y, Huang D, Tang L, Hou W, Kuang Z, Chen Y, Xiao S, Yishake M, He R.
    J Cell Mol Med; 2020 Sep 05; 24(18):10444-10457. PubMed ID: 32681612
    [Abstract] [Full Text] [Related]

  • 14. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
    Aono J, Suzuki J, Iwai M, Horiuchi M, Nagai T, Nishimura K, Inoue K, Ogimoto A, Okayama H, Higaki J.
    Arterioscler Thromb Vasc Biol; 2012 Jun 05; 32(6):1453-9. PubMed ID: 22460554
    [Abstract] [Full Text] [Related]

  • 15. Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice.
    Nencioni A, da Silva RF, Fraga-Silva RA, Steffens S, Fabre M, Bauer I, Caffa I, Magnone M, Sociali G, Quercioli A, Pelli G, Lenglet S, Galan K, Burger F, Vázquez Calvo S, Bertolotto M, Bruzzone S, Ballestrero A, Patrone F, Dallegri F, Santos RA, Stergiopulos N, Mach F, Vuilleumier N, Montecucco F.
    Thromb Haemost; 2014 Feb 05; 111(2):308-22. PubMed ID: 24196571
    [Abstract] [Full Text] [Related]

  • 16. Molecular imaging of MMP activity discriminates unstable from stable plaque phenotypes in shear-stress induced murine atherosclerosis.
    Seifert R, Kuhlmann MT, Eligehausen S, Kiefer F, Hermann S, Schäfers M.
    PLoS One; 2018 Feb 05; 13(10):e0204305. PubMed ID: 30304051
    [Abstract] [Full Text] [Related]

  • 17. Corilagin Counteracts IL-13Rα1 Signaling Pathway in Macrophages to Mitigate Schistosome Egg-Induced Hepatic Fibrosis.
    Li YQ, Chen YF, Dang YP, Wang Y, Shang ZZ, Ma Q, Wang YJ, Zhang J, Luo L, Li QQ, Zhao L.
    Front Cell Infect Microbiol; 2017 Feb 05; 7():443. PubMed ID: 29094025
    [Abstract] [Full Text] [Related]

  • 18. Raloxifene inhibits matrix metalloproteinases expression and activity in macrophages and smooth muscle cells.
    Bellosta S, Baetta R, Canavesi M, Comparato C, Granata A, Monetti M, Cairoli F, Eberini I, Puglisi L, Corsini A.
    Pharmacol Res; 2007 Aug 05; 56(2):160-7. PubMed ID: 17582780
    [Abstract] [Full Text] [Related]

  • 19. Bioinformatics analysis of vascular RNA-seq data revealed hub genes and pathways in a novel Tibetan minipig atherosclerosis model induced by a high fat/cholesterol diet.
    Pan Y, Yu C, Huang J, Rong Y, Chen J, Chen M.
    Lipids Health Dis; 2020 Mar 25; 19(1):54. PubMed ID: 32213192
    [Abstract] [Full Text] [Related]

  • 20. Effect of hormone replacement therapy in matrix metalloproteinase expression and intimal hyperplasia development after vascular injury.
    Mountain DJ, Freeman MB, Kirkpatrick SS, Cook RB, Chalk JE, Stevens SL, Goldman MH, Grandas OH.
    Ann Vasc Surg; 2013 Apr 25; 27(3):337-45. PubMed ID: 23088810
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.